This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Alexander Link
Senior Director of Immune-Oncology Research at Molecular Partners
Speaker

Profile

Alex Link is senior director of immune-oncology research at Molecular Partners based in Zurich. His role is primarily to manage and guide research and early development of immune engager programs based on Molecular Partner’s DARPin platform.

Alex is an immunologist by training (PhD Lausanne University) with over 15 years’ experience in Biotech R&D. Over his career to date, his work comprises research on cytokines, chemokines and tertiary lymphoid structures as well as therapeutic projects across immunology and oncology with recent focus on immune engagers and costimulatory agents for cancer immunotherapy.

Agenda Sessions

  • Logic-gated Conditional Switch-DARPin T cell Engagers with CD2 Costimulation for Effective Immunotherapy of Solid Cancers with Favorable Therapeutic Window

    14:35